287 systems in 25% less time and 20% under budget

FDA Mandated Global CSV Remediation

Charged with reassessing nearly 2,000 GxP software applications in the wake of unsavory FDA audit findings, a $7.5B annual revenue, global medical device company teamed up with USDM to meet CSV standards.

Find out how we assuaged the company’s plight by engaging with them at key stages and utilizing the systems expertise of our Senior Consultants to ultimately reduce the scope of the issue, remediate systems and conserve time and money.
 

The Situation

  • FDA audit findings required that approximately 2,000 GxP software applications be assessed for remediation to current CSV standards and procedures
  • FDA completion commitment timeline was 12 months
  • Systems included enterprise, spreadsheet and business unit specific systems cross organization (including cloud, in-house developed, LMS, ERP, Lab, manufacturing, clinical, etc.) 
  • Systems ranged in both risk and complexity
USDM performed a detailed assessment of all systems determined by client to be GxP compliant and reduced the number of systems in the client’s original scope by over 80%

We ensured that proper justification was in alignment with both customer SOPs and global regulatory guidelines, leveraged existing documents wherever possible and developed a streamlined risk program.

  • USDM managed the program and remediated 287 systems – including 86 that were identified by client during the project and initially out of scope.
  • Team of highly skilled Sr. Consultants, onsite and remote testers and technical writers produced further cost savings.
  • Performed Audit Readiness Training to prepare Client teams in Quality, IT and the business.

$600k Under Budget Based on Efficient Delivery

Project completed in 25% less time

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.